Lantheus sank -4.9% this afternoon, compared to the S&P 500's day change of 1.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Lantheus has logged a -9.0% 52 week change, compared to 10.0% for the S&P 500
-
LNTH has an average analyst rating of buy and is -40.9% away from its mean target price of $121.75 per share
-
Its trailing earnings per share (EPS) is $-0.25, which brings its trailing Price to Earnings (P/E) ratio to -287.8. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $6.09 and its forward P/E ratio is 11.8
-
The company has a Price to Book (P/B) ratio of 8.91 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 2.7, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
LNTH has reported YOY quarterly earnings growth of 118.0% and gross profit margins of 0.6%
-
The company's free cash flow for the last fiscal year was $298.33 Million and the average free cash flow growth rate is 30.6%
-
Lantheus's revenues have an average growth rate of 28.1% with operating expenses growing at -45.1%. The company's current operating margins stand at 3.9%